Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Genomics02:02

Genomics

35.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.6K
Genetic Screens02:46

Genetic Screens

4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

264
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
264
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A dedicated caller for DUX4 rearrangements from whole-genome sequencing data.

BMC medical genomics·2025
Same author

The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.

Blood·2023
Same author

Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases.

Cell genomics·2023
Same author

Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.

Leukemia·2023
Same author

Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.

Leukemia·2022
Same author

Publisher Correction: Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.

The pharmacogenomics journal·2022

関連する実験動画

Updated: May 7, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

36.1K

薬のためのゲノム.

David R Bentley1

  • 1The Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. drb@sanger.ac.uk

Nature
|May 28, 2004
PubMed
まとめ
この要約は機械生成です。

人間のゲノム配列はほぼ完成し,利用可能だが,医学的な応用には高品質の注釈が必要である. ゲノム医学を前進させるために,さらなるシーケンシング,実験分析,およびフェノタイプデータは極めて重要です.

さらに関連する動画

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

12.4K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.6K

関連する実験動画

Last Updated: May 7, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

36.1K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

12.4K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.6K

科学分野:

  • ゲノミクスゲノミクスとは
  • バイオインフォマティックス
  • 医学遺伝学 医学遺伝学

背景:

  • 人間のゲノム配列は,ほぼ完全で自由にアクセスできるリソースです.
  • その現在の状態は,臨床医学の直接的な適用に課題を提示しています.
  • 遺伝子研究の進歩は,このゲノムデータによって推進されています.

研究 の 目的:

  • 医学的な応用のためのヒトゲノム配列の準備を評価する.
  • ゲノムデータを臨床実践に翻訳するために必要なステップを特定する.
  • 高品質のゲノムアノテーションとデータ統合の重要性を強調する.

主な方法:

  • ヒトゲノムシーケンシングとアノテーションの現状のレビュー.
  • 医学的に重要な遺伝子変異を特定するための戦略の分析.
  • ゲノム情報をフェノタイプデータと統合するための要件の評価.

主要な成果:

  • 人間のゲノム配列は強力なリソースですが,医学的な用途のためにさらに精錬する必要があります.
  • 機能的なシーケンスやバリエーションの高品質なアノテーションは不可欠です.
  • ゲノムシーケンシング,実験的検証,およびフェノタイプデータを増加させる必要がある.

結論:

  • 人間のゲノムは,医学的な応用が広範囲に及ぶには,まだ完全に準備ができていない.
  • 総合的な注釈とデータ統合は,臨床的可能性を解き放つために不可欠です.
  • アノテーションされたゲノムへのユーザーフレンドリーなアクセスは,生物医学研究と実践におけるイノベーションを助長します.